Business Segments · Net Sales
MedSurg and Neurotechnology: — Net Sales
Stryker MedSurg and Neurotechnology: — Net Sales decreased by 46.7% to $3.21B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 45.3%, from $5.87B to $3.21B. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026May 11, 2026
Rolls up toTotal Revenue
How to read this metric
An increase indicates growing market share or higher demand for the segment's medical devices, while a decrease suggests potential market saturation or competitive pressure.
Detailed definition
Represents the total revenue generated from the sale of medical surgical equipment, neurotechnology devices, and related...
Peer comparison
Comparable to segment-level revenue reporting in other diversified medical device manufacturers.
Metric ID:
syk_segment_medsurg_and_neurotechnology_net_salesHistorical Data
40 periods
| Q2 '21 | Q2 '21 | Q3 '21 | Q3 '21 | Q4 '21 | Q4 '21 | Q1 '22 | Q1 '22 | Q2 '22 | Q2 '22 | Q3 '22 | Q3 '22 | Q4 '22 | Q4 '22 | Q1 '23 | Q1 '23 | Q2 '23 | Q2 '23 | Q3 '23 | Q3 '23 | Q4 '23 | Q4 '23 | Q1 '24 | Q1 '24 | Q2 '24 | Q2 '24 | Q3 '24 | Q3 '24 | Q4 '24 | Q4 '24 | Q1 '25 | Q1 '25 | Q2 '25 | Q2 '25 | Q3 '25 | Q3 '25 | Q4 '25 | Q4 '25 | Q1 '26 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.29B | $2.36B | $4.16B | $2.35B | $4.7B | $2.64B | $4.28B | $2.42B | $4.49B | $2.55B | $4.48B | $2.59B | $5.2B | $3.33B | $4.78B | $2.69B | $5B | $2.86B | $4.91B | $2.86B | $5.82B | $3.75B | $5.24B | $3.1B | $5.42B | $3.22B | $5.49B | $3.32B | $6.44B | $3.88B | $5.87B | $3.06B | $6.02B | $3.77B | $6.06B | $3.8B | $7.17B | $4.56B | $6.02B | $3.21B |
| QoQ Change | — | -45.1% | +76.3% | -43.5% | +100.1% | -43.9% | +62.0% | -43.3% | +85.4% | -43.3% | +75.7% | -42.2% | +101.0% | -35.9% | +43.4% | -43.7% | +85.7% | -42.8% | +71.6% | -41.8% | +103.4% | -35.4% | +39.7% | -40.9% | +75.1% | -40.7% | +70.9% | -39.5% | +93.6% | -39.7% | +51.1% | -47.9% | +97.1% | -37.4% | +60.6% | -37.2% | +88.6% | -36.4% | +32.0% | -46.7% |
| YoY Change | — | — | — | — | — | — | — | — | +4.6% | -40.6% | +7.7% | -37.8% | +10.7% | -29.1% | +11.8% | -37.1% | +11.2% | -36.3% | +9.6% | -36.2% | +11.8% | -27.8% | +9.7% | -35.2% | +8.5% | -35.6% | +11.9% | -32.3% | +10.7% | -33.2% | +11.9% | -41.7% | +11.1% | -30.5% | +10.2% | -30.8% | +11.4% | -29.1% | +2.6% | -45.3% |
Range$2.35B – $7.17B
CAGR-2.9%
Avg YoY Growth-12.6%
Median YoY Growth-12.6%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's medsurg and neurotechnology: — net sales?
- Stryker (SYK) reported medsurg and neurotechnology: — net sales of $3.21B in Q1 2026.
- How has Stryker's medsurg and neurotechnology: — net sales changed year-over-year?
- Stryker's medsurg and neurotechnology: — net sales decreased by 45.3% year-over-year, from $5.87B to $3.21B.
- What does medsurg and neurotechnology: — net sales mean?
- The total revenue earned from the MedSurg and Neurotechnology business segment.